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Abstract Many RNA polymerase II- or Ill-transcribed genes 
are inactive when their promoter is methylated at critical CpG 
dinucleotides. We have applied the genomic sequencing method 
and a direct DNA blotting technique to analyze the extent of 
DNA methylation in the 5'-CpG-3' rich promoter region of the 
RNA polymerase I-transcribed ribosomal RNA genes (rDNA) in 
DNA from primary human cells, primary human tumor cells and 
human cell lines. In none of the analyzed primary human cells 
and primary human tumor cells was the DNA in the rDNA 
promoter region found to be detectably methylated. In contrast, 
in some of the cell lines this promoter is methylated in all 5'- 
CpG-3' dinucleotides in the majority of the approximately 200 
ribosomal RNA gene copies. In actively growing cells, rDNA 
gene activity is a prerequisite for cell viability. The high levels of 
DNA methylation in the promoter egion of rDNA in the human 
cell lines raise questions on the role of promoter methylation in 
these RNA polymerase I-transcribed genes. It is, however, 
conceivable that a subset of the about 200 rDNA copies per 
haploid genome have escaped methylation and account for the 
rRNA synthesis in these cell lines. Alternatively, complete 5'- 
CpG-3' promoter methylation may be compatible with promoter 
activity as demonstrated for certain viral genomes. 
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1. Introduction 
DNA methylation entails long-term inactivation of mam- 
malian RNA polymerase II- and III-transcribed genes (for 
reviews, see [1,2]). Since the three different eukaryotic RNA 
polymerases share certain protein components and transcrip- 
tion factors [3-7], DNA methylation might also have a func- 
tion in the control of RNA polymerase I-transcribed genes. 
We have analyzed deoxycytidine methylation in the promoter 
region of the RNA polymerase I-transcribed ribosomal RNA 
genes in different primary human cells, in primary human 
tumor cells, and in human cell lines. 
Since the promoter region of the human ribosomal RNA 
genes is extraordinarily rich in 5'-CpG-3' dinucleotides, 
*Corresponding author. Fax: (49) (221) 470-5163. 
E-mail: doerfler@scan.genetik.uni-koeln.de 
**Present address: Department of Molecular and Human Genetics, 
Baylor College of Medicine, Houston, TX 77030, USA. 
***Present address: Institute of Bio-Microbiology, 2-2-7 Minowa, 
Taito-ku, Tokyo-ll0 and Blood Center, Japanese Red Cross, 
Okayama, Japan. 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. 
P I IS0014-5793(96)00506-6  
methylation-sensitive restriction endonucleases are not useful 
in precisely determining the extent of DNA methylation in 
this DNA segment. We have, therefore, chosen the genomic 
sequencing technique to assess the methylation status of each 
deoxycytidine in a region of approximately 350 base pairs (bp) 
in the rDNA promoter. The multiple copy nature and the 
high degree of sequence conservation in the ribosomal RNA 
genes, which are located on human chromosomes 13, 14, 15, 
21, and 22, have facilitated this analysis [8]. 
2. Materials and methods 
2.1. Primary cells, cell lines and extraction of DNA 
The derivation of the primary human cells and human cell lines 
have been described in detail [9,10]. Briefly, DEV is a human Hodgkin 
lymphoma cell line, Jurkat and CEM are T cell lines, 660 is a B-cell 
leukemia line, and KB and HeLa are epithelial cell lines established 
from human tumors. 
The extraction of cellular DNA followed standard protocols [10,11]. 
2.2. Genomic sequencing 
Plasmid pBE2A carrying a fragment of the human rRNA gene 
encompassing ucleotides -513 to +696 was obtained from M. Mura- 
matsu [12]. Cellular DNA was cut with the restriction endonuclease 
BstEII, which cleaved 80 bp downstream from the start site of tran- 
scriptional initiation in the RNA polymerase 1-transcribed ribosomal 
genes (Fig. 1). 
The original genomic sequencing method [13] was applied. Hydra- 
zinc, which distinguished between methylated and unmethylated 
deoxycytidines (C), and the deoxyguanosine-specific dimethylsulfate 
(DMS) were allowed to react with 1-2/.tg of genomic DNA at 20°C 
for 10 and 4 min, respectively. Upon chemical cleavage of the reaction 
products with 1 M piperidine at 90°C, the DNAs were ethanol pre- 
cipitated and lyophilized twice. DNA fragments were subsequently 
separated by electrophoresis on 0.19 mm thin, 8% polyacrylamide 
gels in TBE (0.1 M Tris, 0.77 M borate, 25 mM EDTA, pH 8.3) 
containing 8 M urea. During electrophoresis at 1750 V and 13 mA, 
DNA fragments were directly blotted onto uncharged nylon mem- 
branes in a transfer APPARATUS (MWG Biotech, Constance, Ger- 
many). The running speed of the supporting belt was 8 cm/h. At the 
end of electrophoresis, the DNA was fixed to the nylon membrane by 
irradiation with 254 nm UV light for 3 min at a distance of 20 cm. 
A 587 bp EcoRI-BstElI fragment encompassing the rDNA promo- 
ter and the first 80 hp of the external transcribed spacer of the ribo- 
somal RNA genes was cloned into the EcoRI and BamHI cloning sites 
of phage M13mpl8 or M13mpl9 DNA (Fig. 1). After the annealing 
of appropriate primers, single-stranded DNA probes were generated 
using the Klenow fragment [14] of the E. coli DNA polymerase [15] 
and 125-250 ~Ci of c~[32P]dCTP (6000 Ci/mmol). Primer rDNA 1, 
bottom, had the nucleotide sequence 5'-GTCACCGGTAGGCCA- 
GAGCC-3'. After the labeling reaction, the product was cleaved 
with HinfI. Primer rDNA 2, top, had the sequence 5'- 
TTCGCTCCGAGTCGGCATTT-Y. After the labeling reaction, the 
product was cleaved with BamHI in the polylinker sequence (Fig. 1). 
Single-stranded probes were purified by polyacrylamide gel electro- 
phoresis under denaturing conditions, followed by electroelution. Hy- 
bridization was performed as described [13]. 
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Fig. 1. Map of the human RNA polymerase I-transcribed ribosomal RNA genes with the locations of some of the restriction sites and all 5'- 
CpG-3' dinucleotides (vertical bars). The genomic sequencing strategy is also explained. Genomic DNA was cleaved with BstEII and subjected 
to the chemical sequencing reactions (for details see Section 2). Oligodeoxyribonucleotide primers rDNA 2, top, and rDNA 1, bottom, were 
used for the synthesis of 32P-labeled single-stranded DNA probes (solid line). TSS: transcription start site. The BamHI site was located outside 
the ribosomal RNA gene in the polycloning site. 
3. Results and discussion 
An autoradiogram of a genomic sequencing experiment of 
the bottom strand of the promoter egion of the ribosomal 
RNA genes is shown in Fig. 2. In lanes 1-8, the G sequencing 
ladders for DNAs from different human cell lines and primary 
human cells are presented. In lanes 9-16, the C reaction prod- 
ucts of DNA from the same cell types are analyzed. All deox- 
ycytidines in the 5'-CpG-3' positions are indicated by arrow- 
heads. 
In the DNAs from primary human granulocytes (G) and 
spermatozoa (Sp), (Fig. 2, lanes 15 and 16, respectively), the 
intensities of the C bands in the 5'-CpG-3' positions were 
identical when compared to the intensities of the C bands in 
non-5'-CpG-3' positions within the same lanes. Thus, deoxy- 
cytidine methylation i  5'-CpG-3' positions was not detect- 
able by this method in the DNAs of these cells. Similar results 
were obtained with the DNAs from the human cell lines 660 
and DEV (lanes 9 and 14, respectively), with DNA from pri- 
mary human T lymphocytes, and with DNA from a chronic T 
cell leukemia (T-CCL), a chronic B cell leukemia (B-CLL), or 
a chronic myelocytic leukemia (CML) (data not shown and 
Table 1). Details of the isolation of human T cells and of the 
cells from the human leukemias have been published pre- 
viously [ 16]. 
In contrast, in the DNAs from the human cell lines CEM, 
KB, HeLa, and Jurkat (Fig. 2, lanes 10, 11, 12, 13, respec- 
tively), a very marked ecrease in the intensities of all C bands 
in the 5'-CpG-3' positions was apparent when compared to 
the intensities of C bands in non-5'-CpG-3' positions in the 
same lanes. 
Densitometric comparisons of signal intensities between un- 
methylated non-5'CpG-3' and partly methylated 5'-CpG-3' 
positions revealed average reductions in band intensities due 
to C-residues in 5'-CpG-3' positions to a level of about 15% 
for the DNA from cell line Jurkat, to a level of about 20% for 
the DNA from cell lines CEM, to a level of 50% for the DNA 
from the KB cell line and to a level of 35% for the DNA from 
the HeLa cell line. There was some variation between different 
5'-CpG-3' sequences in the same lanes. Hence, in the DNAs 
from cell lines Jurkat, CEM, KB, and HeLa about 85%, 80%, 
50%, and 65% of the rDNA copies, respectively, were methy- 
lated in 5'-CpG-3' dinucleotides (Table 1). 
Identical results were obtained with the opposite DNA 
strand as hybridization probe (data not shown). The possibil- 
ity of C-residue mutations being responsible for the observed 
differences in C signal intensities between 5'-CpG-3' and non- 
5'-CpG-3' positions in the DNA from some of the cell lines 
was excluded by performing DMS (G) reactions for both 
DNA strands in all analyzed DNA samples. For each C 
residue in one strand, a G residue was found in the corre- 
sponding position of the complementary strand in the seg- 
ments analyzed. In these experiments, we never observed C 
Table 1 
Extent of 5'-CpG-3' methylation i  the promoter egion of riboso- 
mal RNA genes a 
Source of DNA Percent methylation b in 
5'-CpG-3' dinucleotides 
Human cell lines 
Jurkat (T cell) 85 
CEM (T cell) 80 
HeLa (cervical cancer) 65 
KB (oral cancer) 50 
DEV (Hodgkin lymphoma) 0 
660 (B cell) 0 
Primary human cell types 
Primary human granulocytes 0 
Primary human T lymphocytes 0 
Human spermatozoa 0 
Primary human tumor cells 
Chronic T cell leukemia T-CCL 0 
Chronic myeloic leukemia CML 0 
Chronic B cell leukemia B-CLL 0 
aln this report, we examined only 350 bp in the 5' upstream region of 
the ribosomal RNA genes. It was not known whether there were 
methylated sequences in regions located further upstream. 
bThese values are based on the densitometric evaluation of several 
autoradiograms and intensity comparisons between 5'-CpG-3' located 
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Fig. 2. Autoradiogram of a genomic sequencing experiment. The 
bottom strand between map positions -110 and +17 is shown. The 
arrowheads point to deoxycytidine r sidues in 5'-CpG-3' positions. 
Lanes 1-8, DMS (G) reactions; lanes 9-16, hydrazine (C) reactions 
of different human DNA preparations whose sources were as fol- 
lows: lanes 1 and 9, cell line 660; lanes 2 and 10, cell line CEM; 
lanes 3 and 11, cell line KB; lanes 4 and 12, cell line HeLa; lanes 5 
and 13, cell line Jurkat; lanes 6 and 14, cell line DEV; lanes 7 and 
15, human granulocytes (G); lanes 8 and 16, human spermatozoa 
(Sp). TSS: transcription start site. 
residue methylations in positions other than in 5'-CpG-3' di- 
nucleotides. However, using this genomic sequencing tech- 
nique, the methylation of an occasional C-residue in 5'- 
CpG-3' or in non-5'-CpG-3'  positions in some of the 200 
rDNA copies per haploid genome could not be excluded. 
It is not possible to interpret hese data in terms of rDNA 
function, as it is unknown whether promoter methylation of 
rDNA genes affects transcriptional ctivity of these multiple 
copy genes. The finding of 50-80°/'0 levels of rDNA promoter 
methylation in several fast growing cell lines might be recon- 
ciled with rDNA gene activity in cell culture as a fundamental 
prerequisite of cell viability. The ribosomal genes occur in 
multiple copies and the activity of some of these genes might 
suffice for cell growth in culture. By Southern blot analyses, 
we have excluded significant amplifications of the rDNA 
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genes in the cell lines with high levels of rDNA methylation 
(data not shown). 
Extrachromosomal ribosomal DNA from Xenopus laevis 
sperm has been found to be methylated at every 5'-CpG-3' 
in the promoter egion of rDNA. Upon injection into Xenopus 
laevis oocytes, methylated and unmethylated rDNA con- 
structs have been transcribed equally well [17]. These findings 
suggest hat complete 5'-CpG-3' methylation of the rDNA 
promoter may not interfere with promoter activity. Perhaps, 
a specific subset of the 5'-CpG-3' sites would lead to promo- 
ter inactivation, similarly to one of the frog virus 3 promoters 
which became inactivated only when the 5'-CCGG-3'  se- 
quences were selectively and exclusively methylated [18]. 
Moreover, in wheat, the proportion of rDNA repeat units 
with methylated 5'-CCGG-3'  (HpalI) sites has been found 
to be related to the number of rDNA genes in the cells. The 
total number of unmethylated 5' -CCGG-3'  sites in possibly 
actively transcribed rDNA is thought o be relatively constant 
between different genotypes [19]. 
We have to reserve judgement on the interpretation of our 
present data, until functional data on the effect of DNA methyl- 
ation on the activity of the RNA polymerase I-transcribed 
rDNA genes in human cells and cell lines become available. 
Acknowledgements. We thank M. Muramatsu, Department of Bio- 
chemistry, Saitama University Medical School, Saitama, Japan, for a 
plasmid containing the cloned fragment from human ribosomal DNA 
and P. B6hm for expert editorial work. This research was supported 
by the Deutsche Forschungsgemeinschaft t rough SFB274-A1 and by 
the Thyssen Stiftung, Cologne, by a Heiwa Nakajima Foundation 
Fellowship to W.D. and by a grant-in-aid from Kawasaki Medical 
School. 
References 
[1] Doerfler, W. (1983) Annu. Rev. Biochem. 52, 93-124. 
[2] Doerfler, W. (1993) in: DNA Methylation: Molecular Biology 
and Biological Significance (Jost, J.P. and Saluz, H.P., Eds.), 
pp. 262-299, Birkh~iuser, Basel. 
[3] Sentenac, A. (1985) Crit. Rev. Biochem. 18, 31-90. 
[4] Goodrich, J.A. and Tjian, R. (1994) Curr. Opin. Cell Biol. 6, 
403-409. 
[5] Cormack, B.P. and Struhl, K. (1992) Cell 69, 685~596. 
[6] Sharp, P.A. (1992) Cell 68, 819-821. 
[7] Comai, L., Tenese, N. and Tjian, R. (1992) Cell 68, 965476. 
[8] Henderson, S.A., Warburton, D. and Atwood, K.C. (1972) Proc. 
Natl. Acad. Sci. USA 69, 3394-3398. 
[9] Kochanek, S., Toth, M., Dehmel, A., Renz, D. and Doerfler, W. 
(1990) Proc. Natl. Acad. Sci. USA 87, 8830-8834. 
[10] Achten, S., Behn-Krappa, A., Jticker, M., Sprengel, J., H61ker, 
I., Schmitz, B., Tesch, H., Diehl, V. and Doerfler, W. (1991) 
Cancer Res. 51, 3702-3709. 
[11] Sutter, D., Westphal, M. and Doerfler, W. (1978) Cell 14, 569- 
585. 
[12] Wilson, G.N., Hollar, B.A., Waterson, J.R. and Schmickel, R.D. 
(1978) Proc. Natl. Acad. Sci. USA 75, 5367-5371. 
[13] Church, G.M. and Gilbert, W. (1984) Proc. Natl. Acad. Sci. 
USA 81, 1991-1995. 
[14] Klenow, H., Overgaard-Hansen, K. and Patkar, S.A. (1971) Eur. 
J. Biochem. 22, 371-381. 
[15] Lehman, I.R., Bessman, M.J., Simms, E.S. and Kornberg, A. 
(1958) J. Biol. Chem. 233, 163-170. 
[16] Kochanek, S., Radbruch, A., Tesch, H., Renz, D. and Doerfler, 
W. (1990) Proc. Natl. Acad. Sci. USA 88, 5759-5763. 
[17] McLeod, D. and Bird, A. (1983) Nature 306, 200-203. 
[18] Munnes, M., Schetter, C., H61ker, I. and Doerfler, W. (1995) 
J. Virol. 69, 2240-2247. 
[19] Flavell, R.B., O'Dell, M. and Thompson, W.F. (1988) J. Mol. 
Biol. 204, 523-534. 
